Nuvectis Pharma Inc. (NASDAQ: NVCT)
$6.96
+0.3050 ( +4.59% ) 61.8K
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Market Data
Open
$6.96
Previous close
$6.65
Volume
61.8K
Market cap
$126.66M
Day range
$6.69 - $7.07
52 week range
$5.85 - $15.96
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 6 | Apr 29, 2024 |
4 | Insider transactions | 1 | Mar 19, 2024 |
8-k | 8K-related | 16 | Mar 05, 2024 |
10-k | Annual reports | 80 | Mar 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
10-q | Quarterly Reports | 45 | Nov 08, 2023 |
8-k | 8K-related | 14 | Nov 08, 2023 |
4 | Insider transactions | 1 | Oct 12, 2023 |
4 | Insider transactions | 1 | Oct 10, 2023 |